Stem Cell Cryopreservation Medium

Ordering Information of Stem Cell Cryopreservation Medium

For details about the products, delivery terms or price quote, please contact us!

What is MSC Cryopreservation Medium?

MSC cryopreservation medium, also known as mesenchymal cryopreservation medium, is a specialized formulation designed for the long-term cryogenic storage of mesenchymal stem cells (MSCs) at ultra-low temperatures, typically in liquid nitrogen (-196°C). Its core objective is to preserve high post-thaw viability, efficient recovery, and essential functions — including proliferation, multi-lineage differentiation, immunomodulation, and therapeutic potency — ensuring suitability for research, regenerative medicine, and clinical applications. Traditional MSC cryopreservation medium relies on dimethyl sulfoxide (DMSO) (5–10%) as the main penetrating cryoprotectant to prevent intracellular ice formation, osmotic stress, and membrane rupture. This cell freezing media DMSO often paired with serum (e.g., FBS or human platelet lysate) or albumin for stability. However, DMSO's potential cytotoxicity — to cells during exposure and to patients during infusion — drives ongoing advancements toward DMSO-reduced or DMSO-free alternatives. These incorporate penetrating agents (e.g., glycerol, ethylene glycol) and non-penetrating protectants (e.g., trehalose, sucrose, isoleucine, polymers like PVA). Chemically defined, serum-free, animal component-free options deliver comparable or superior post-thaw performance, enhanced safety, consistency, and regulatory compliance across MSC sources (bone marrow, adipose, umbilical cord).

Key Features of MSC Cryopreservation Media

Effective mesenchymal cryopreservation medium and MSC cryopreservation medium are engineered to ensure safe, reliable long-term storage while meeting stringent regulatory standards for research and clinical applications. The essential features include:

• Xeno-Free Composition — Completely free of animal-derived components (e.g., no fetal bovine serum or other xenogenic materials), eliminating risks of immunogenicity, zoonotic pathogen transmission, and batch-to-batch variability. This is critical for GMP-compliant, clinical-grade products and patient safety.

• Chemically Defined Formulation — Composed of precisely known, synthetic ingredients with no undefined elements, ensuring reproducibility, consistency across lots, and full traceability. This supports standardized manufacturing and regulatory approval.

• High Post-Thaw Viability and Recovery — Delivers excellent cell survival rates (typically >90%), rapid attachment, proliferation, and functional recovery after thawing. Optimized media preserve spindle-shaped morphology, surface markers, multipotency, and therapeutic properties like immunomodulation and differentiation potential.

• Robust Cryoprotective Agents — Incorporate effective cryoprotectants to prevent ice crystal formation, osmotic injury, and membrane damage during controlled-rate freezing and thawing. Traditional options include 5–10% DMSO, but advanced media favor DMSO-reduced or fully DMSO-free alternatives for reduced toxicity, better infusion safety, and compatibility with serum-free/xeno-free workflows.

You may also like:

• iPSC freezing media

Talk to our experts for more help.